Amedisys has a twelve month low of $82.15 and a twelve month high of $98.95. Get Amedisys alerts: Amedisys (NASDAQ:AMED – Get Free Report) last announced its quarterly earnings results on ...

Shares of NASDAQ AMED opened at $92.60 on Wednesday. The company’s 50-day simple moving average is $90.11 and its 200-day simple moving average is $93.58. Amedisys has a 52-week low of $82.15 ...

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month ...

WILMINGTON, N.C. (WECT) - The town of Leland held a Public Budget Q&A forum on Tuesday night. Staff presented the Proposed Fiscal Year 25-26 Budget to the community. They opened the floor to questions ...

UnitedHealth Group and Amedisys outlined plans to divest a significant number of home health and hospice locations as they seek to close their $3.3 billion merger. In a court filing issued late ...

William Blair analyst Matt Larew maintained a Hold rating on Amedisys (AMED – Research Report) today. The company’s shares closed yesterday at $91.57. See what stocks are receiving Strong Buy ...

Amedisys, for the fourth quarter of 2024, delivers year-over-year top-line growth across three of its segments - Home Health, Hospice and High Acuity Care. While the top- and bottom-line numbers ...

BATON ROUGE, La., Feb. 26, 2025 (GLOBE NEWSWIRE) -- Amedisys, Inc. (NASDAQ: AMED) today reported its financial results for the three-month period and year ended December 31, 2024. Three-Month Periods ...

BATON ROUGE, La. (AP) — BATON ROUGE, La. (AP) — Amedisys Inc. (AMED) on Wednesday reported a fourth-quarter loss of $20.4 million, after reporting a profit in the same period a year earlier.

In light of the pending merger of the Company with UnitedHealth Group Incorporated, Amedisys will not conduct a quarterly earnings call to discuss the fourth quarter and year end results.